Dengue Vaccines Industry Research Report 2025

Summary

Dengue vaccine is a vaccine used to prevent dengue fever in humans. As of 2019, one version is commercially available, known as CYD-TDV, and sold under the brand name Dengvaxia. The vaccine is only recommended in those who have previously had dengue fever or populations in which most people have been previously infected. The value of the vaccine is limited by the fact that it may worsen outcomes in those who have not previously been infected. It is given as three injections over a year.

According to APO Research, The global Dengue Vaccines market was valued at US$ million in 2024 and is anticipated to reach US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2025-2031.

North American market for Dengue Vaccines is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Dengue Vaccines is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Dengue Vaccines is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of Dengue Vaccines include Sanofi and Takeda, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Dengue Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Dengue Vaccines.
The Dengue Vaccines market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Dengue Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.

Dengue Vaccines Segment by Company

Sanofi
Takeda
Dengue Vaccines Segment by Type

Dengvaxia
TAK-003
Others
Dengue Vaccines Segment by Application

Public Sector
Private Sector
Dengue Vaccines Segment by Application

Public Sector
Private Sector
Dengue Vaccines Segment by Region

North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Dengue Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Dengue Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Dengue Vaccines.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Dengue Vaccines companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.


1 Preface
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 Market Overview
2.1 Product Definition
2.2 Dengue Vaccines by Type
2.2.1 Market Value Comparison by Type (2020 VS 2024 VS 2031)
2.2.2 Dengvaxia
2.2.3 TAK-003
2.2.4 Others
2.3 Dengue Vaccines by Application
2.3.1 Market Value Comparison by Application (2020 VS 2024 VS 2031)
2.3.2 Public Sector
2.3.3 Private Sector
2.4 Assumptions and Limitations
3 Dengue Vaccines Breakdown Data by Type
3.1 Global Dengue Vaccines Historic Market Size by Type (2020-2025)
3.2 Global Dengue Vaccines Forecasted Market Size by Type (2026-2031)
4 Dengue Vaccines Breakdown Data by Application
4.1 Global Dengue Vaccines Historic Market Size by Application (2020-2025)
4.2 Global Dengue Vaccines Forecasted Market Size by Application (2026-2031)
5 Global Growth Trends
5.1 Global Dengue Vaccines Market Perspective (2020-2031)
5.2 Global Dengue Vaccines Growth Trends by Region
5.2.1 Global Dengue Vaccines Market Size by Region: 2020 VS 2024 VS 2031
5.2.2 Dengue Vaccines Historic Market Size by Region (2020-2025)
5.2.3 Dengue Vaccines Forecasted Market Size by Region (2026-2031)
5.3 Dengue Vaccines Market Dynamics
5.3.1 Dengue Vaccines Industry Trends
5.3.2 Dengue Vaccines Market Drivers
5.3.3 Dengue Vaccines Market Challenges
5.3.4 Dengue Vaccines Market Restraints
6 Market Competitive Landscape by Players
6.1 Global Top Dengue Vaccines Players by Revenue
6.1.1 Global Top Dengue Vaccines Players by Revenue (2020-2025)
6.1.2 Global Dengue Vaccines Revenue Market Share by Players (2020-2025)
6.2 Global Dengue Vaccines Industry Players Ranking, 2023 VS 2024 VS 2025
6.3 Global Key Players of Dengue Vaccines Head Office and Area Served
6.4 Global Dengue Vaccines Players, Product Type & Application
6.5 Global Dengue Vaccines Manufacturers Established Date
6.6 Global Dengue Vaccines Market CR5 and HHI
6.7 Global Players Mergers & Acquisition
7 North America
7.1 North America Dengue Vaccines Market Size (2020-2031)
7.2 North America Dengue Vaccines Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 North America Dengue Vaccines Market Size by Country (2020-2025)
7.4 North America Dengue Vaccines Market Size by Country (2026-2031)
7.5 United States
7.5 United States
7.6 Canada
7.7 Mexico
8 Europe
8.1 Europe Dengue Vaccines Market Size (2020-2031)
8.2 Europe Dengue Vaccines Market Growth Rate by Country: 2020 VS 2024 VS 2031
8.3 Europe Dengue Vaccines Market Size by Country (2020-2025)
8.4 Europe Dengue Vaccines Market Size by Country (2026-2031)
8.5 Germany
8.6 France
8.7 U.K.
8.8 Italy
8.9 Spain
8.10 Russia
8.11 Netherlands
8.12 Nordic Countries
9 Asia-Pacific
9.1 Asia-Pacific Dengue Vaccines Market Size (2020-2031)
9.2 Asia-Pacific Dengue Vaccines Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Asia-Pacific Dengue Vaccines Market Size by Country (2020-2025)
9.4 Asia-Pacific Dengue Vaccines Market Size by Country (2026-2031)
9.5 China
9.6 Japan
9.7 South Korea
9.8 India
9.9 Australia
9.10 China Taiwan
9.11 Southeast Asia
10 South America
10.1 South America Dengue Vaccines Market Size (2020-2031)
10.2 South America Dengue Vaccines Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 South America Dengue Vaccines Market Size by Country (2020-2025)
10.4 South America Dengue Vaccines Market Size by Country (2026-2031)
10.5 Brazil
10.6 Argentina
10.7 Chile
10.8 Colombia
10.9 Peru
11 Middle East & Africa
11.1 Middle East & Africa Dengue Vaccines Market Size (2020-2031)
11.2 Middle East & Africa Dengue Vaccines Market Growth Rate by Country: 2020 VS 2024 VS 2031
11.3 Middle East & Africa Dengue Vaccines Market Size by Country (2020-2025)
11.4 Middle East & Africa Dengue Vaccines Market Size by Country (2026-2031)
11.5 Saudi Arabia
11.6 Israel
11.7 United Arab Emirates
11.8 Turkey
11.9 Iran
11.10 Egypt
12 Players Profiled
12.1 Sanofi
12.1.1 Sanofi Company Information
12.1.2 Sanofi Business Overview
12.1.3 Sanofi Revenue in Dengue Vaccines Business (2020-2025)
12.1.4 Sanofi Dengue Vaccines Product Portfolio
12.1.5 Sanofi Recent Developments
12.2 Takeda
12.2.1 Takeda Company Information
12.2.2 Takeda Business Overview
12.2.3 Takeda Revenue in Dengue Vaccines Business (2020-2025)
12.2.4 Takeda Dengue Vaccines Product Portfolio
12.2.5 Takeda Recent Developments
13 Report Conclusion
14 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings